Jonsson EN - Search Results

1

Morphine blood-brain barrier transport is influenced by probenecid co-administration.

Tunblad K, Jonsson EN, Hammarlund-Udenaes M. Tunblad K, et al. Among authors: jonsson en. Pharm Res. 2003 Apr;20(4):618-23. doi: 10.1023/a:1023250900462. Pharm Res. 2003. PMID: 12739770

2

An integrated model for the analysis of pharmacokinetic data from microdialysis experiments.

Tunblad K, Hammarlund-Udenaes M, Jonsson EN. Tunblad K, et al. Among authors: jonsson en. Pharm Res. 2004 Sep;21(9):1698-707. doi: 10.1023/b:pham.0000041468.00587.c6. Pharm Res. 2004. PMID: 15497699

3

Influence of probenecid on the delivery of morphine-6-glucuronide to the brain.

Tunblad K, Hammarlund-Udenaes M, Jonsson EN. Tunblad K, et al. Among authors: jonsson en. Eur J Pharm Sci. 2005 Jan;24(1):49-57. doi: 10.1016/j.ejps.2004.09.009. Eur J Pharm Sci. 2005. PMID: 15626577

4

The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data.

Tunblad K, Lindbom L, McFadyen L, Jonsson EN, Marshall S, Karlsson MO. Tunblad K, et al. Among authors: jonsson en. J Pharmacokinet Pharmacodyn. 2008 Oct;35(5):503-26. doi: 10.1007/s10928-008-9099-z. Epub 2008 Nov 15. J Pharmacokinet Pharmacodyn. 2008. PMID: 19011957

5

Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu).

Gupta A, Chatelain P, Massingham R, Jonsson EN, Hammarlund-Udenaes M. Gupta A, et al. Among authors: jonsson en. Drug Metab Dispos. 2006 Feb;34(2):318-23. doi: 10.1124/dmd.105.007211. Epub 2005 Nov 22. Drug Metab Dispos. 2006. PMID: 16303872

6

Stereoselective pharmacokinetics of cetirizine in the guinea pig: role of protein binding.

Gupta A, Hammarlund-Udenaes M, Chatelain P, Massingham R, Jonsson EN. Gupta A, et al. Among authors: jonsson en. Biopharm Drug Dispos. 2006 Sep;27(6):291-7. doi: 10.1002/bdd.509. Biopharm Drug Dispos. 2006. PMID: 16791848

7

Bridging the pharmacokinetics and pharmacodynamics of UK-279,276 across healthy volunteers and stroke patients using a mechanistically based model for target-mediated disposition.

Jonsson EN, Macintyre F, James I, Krams M, Marshall S. Jonsson EN, et al. Pharm Res. 2005 Aug;22(8):1236-46. doi: 10.1007/s11095-005-5264-x. Epub 2005 Aug 3. Pharm Res. 2005. PMID: 16078133

8

Automated covariate model building within NONMEM.

Jonsson EN, Karlsson MO. Jonsson EN, et al. Pharm Res. 1998 Sep;15(9):1463-8. doi: 10.1023/a:1011970125687. Pharm Res. 1998. PMID: 9755901

9

Discrimination between rival dosing histories.

Jonsson EN, Wade JR, Almqvist G, Karlsson MO. Jonsson EN, et al. Pharm Res. 1997 Aug;14(8):984-91. doi: 10.1023/a:1012184808192. Pharm Res. 1997. PMID: 9279877 Clinical Trial.

10

Likelihood-based diagnostics for influential individuals in non-linear mixed effects model selection.

Sadray S, Jonsson EN, Karlsson MO. Sadray S, et al. Among authors: jonsson en. Pharm Res. 1999 Aug;16(8):1260-5. doi: 10.1023/a:1014857832337. Pharm Res. 1999. PMID: 10468029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters